Public

黑料正能量 Association content that is available to the public and all website users.

This edition of Hacking Healthcare begins by evaluating the National Institute of Standards and Technology鈥檚 (NIST) definition of 鈥渃ritical software鈥 and what that definition might mean for healthcare within the context of the cybersecurity executive order. Next, we take a look at a new US鈥
On July 6, 2021, the Cybersecurity and Infrastructure Security Agency (CISA) and the Federal Bureau of Investigation (FBI) published the Current Activity regarding customers affected by the Kaseya VSA Supply-Chain Ransomware Attack.
The purpose of this joint guidance is to inform the private sector about current activity and actions to take regarding the Kaseya supply-chain ransomware attack that private companies need to be aware of to protect themselves.
Microsoft has provided mitigation guidance to block attacks on systems vulnerable to exploits targeting the Windows Print Spooler zero-day vulnerability known as PrintNightmare. 
On July 2, 2021, the Cybersecurity and Infrastructure Security Agency (CISA) has published the Current Activity regarding the Kaseya VSA Supply-Chain Ransomware Attack.
The Office of Personnel Management, along with the departments of Health and Human Services (HHS), Labor, and Treasury July 1 released 鈥淧art 1鈥 of regulations implementing the No Surprises Act.
The Occupational Safety and Health Administration (OSHA) June 21 published in the Federal Register an emergency temporary standard (ETS) for occupational exposure to COVID-19 that requires health care employers to take certain steps to protect their workers in settings where suspected or confirmed鈥
See who showed up to get their free Covid shot at our first pop-up clinic! It was great to watch folks go from nervous to relieved and excited. Mark your calendar for the next clinic on June 15. We have to protect people of color and that means getting vaccinated. Believe it! pic.twitter.com/鈥
Letter the AHA sent to Senators Grassley and Durbin in support of S. 2304, Drug-Price Transparency for Consumers Act of 2021. The bill will allow HHS to require the disclosure of drug pricing information in direct-to-consumer (DTC) advertising.